Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
49 Cards in this Set
- Front
- Back
drugs used for prevention of clots
|
antiplatelets
|
|
drugs used to act on clotting factors
|
anticoagulants
|
|
drugs used to destroys clots
|
fibrinolytic agents
|
|
Vichow's triad
|
(1) veinous stasis
(2) injury (3) hypercoaguability |
|
the formation of an unwanted clot w/in the blood vessels or heart
|
thrombus
|
|
small part of a clot that breaks off and travels to another part of the vascular system
|
embolus
|
|
red thrombus
|
venous
|
|
white thrombus
|
arterial
|
|
released by adhered platelets to stimulate additional platelet aggregation
|
TXA2 and ADP
|
|
serves as the binding ligand for platelet aggregation
|
fibrin (from fibrinogen)
|
|
what adheres to platelets, causing the release of mediators?
|
vWF
|
|
what inhibits release of granules containing aggregating agents?
|
cAMP
|
|
what binds to platelets and causes cAMP synthesis?
|
Prostacyclin (PGI2)
|
|
arachidonic acid is converted to ___ by ___.
|
PGG2; COX
|
|
PGG2 is metabolized into ___, which promotes platelet clumping.
|
thromboxane A2 (TXA2)
|
|
COX is irreversibly inhibited by ___
|
ASA
|
|
ASA dose for prophylactic use (no MI)
|
81mg or 325mg qd
|
|
ASA dose for prophylactic use (MI)
|
160mg or 325mg qd
|
|
noncompetitive COX inhibitor
|
ASA
|
|
noncompetitive platelet ADP antagonist
|
Clopidogrel (Plavix)
|
|
indications for clopidogrel (plavix)
|
- if pt has CI to ASA
- /p MI, stroke, peripheral artery dz, unstable angina |
|
Abciximab (ReoPro)
Eptifibatide (Integrilin) Tirofiban (Aggastat) |
glycoprotein IIb/IIIa inhibitors
|
|
fragment of a monoclonal antibody that causes binding of the active GPIIb/IIIa receptor site
|
Abciximab (ReoPro)
|
|
natural inhibitors of coagulation
|
- protein C
- protein S - antithrombin III |
|
indications for anticoagulants
|
- DVT (Hx)
- artificial heart valves - atrial fibrillation - protein C/S deficiencies - prophylaxis after surgery |
|
MOA of Heparin (UFH)
|
binds to antithrombin III and speeds its ability to inhibit thrombin
|
|
SEs of Heparin (UFH)
|
- bleeding
- HIT - osteoporosis - hyperkalemia |
|
monitor Heparin (UFH) with
|
activated partial thromboplastin time (aPTT)
|
|
goal of Heparin tx
|
1.5 - 2.5x nml aPTT w/in 24 hrs
|
|
which Heparin work mainly on Xa?
|
LMWH
|
|
which Heparin has better bioavailability and more predictability?
|
LMWH
|
|
Indications for LMWH
|
- prophylaxis and tx of venous thromboembolism, unstable angina, and non-Q-wave MI
- pregnancy (doesn't cross placenta) - use w/ ASA and warfarin |
|
antidote for Heparin overdose
|
protamine sulfate
|
|
dose of protamine sulfate for heparin od
|
1 mg PS:100 units of Heparin
|
|
anticoag which inhibits vit K
|
Warfarin (Coumadin)
|
|
5-7 day steady state of warfarin (coumadin) is based on ___
|
half life of clotting factors
|
|
CIs for warfarin (coumadin)
|
- pregnancy (crosses placenta)
- avoid used w/ NSAIDS (GI bleeding) |
|
INR goal for warfarin (coumadin)
|
INR of 2.5 (3.0 for prosthetic valve replacement pts)
|
|
Warfarin (Coumadin) monitored by
|
INR levels
|
|
antidote for warfarin (coumadin) OD
|
Phytonadione (Vit K)
|
|
How long after phytonadione (vit K) dose will coumadin remain ineffective?
|
2 wks
|
|
replacement drug for Heparin if HIT
|
Bivalirudin (Angiomax)
|
|
specific Factor Xa inhibitor
|
Fondaparinux (Arixtra)
|
|
How soon after clot should thrombolytics be given
|
w/in 12 hrs (best if w/in 3 hrs)
|
|
Indications for thrombolytics
|
- acute MI
- acute ischemic stroke - PE - clear CV catheter |
|
thrombolytics
|
"-ases"
|
|
Streptokinase (Streptase)
Urokinase (Abbokinase) Anistreplase (Eminase) Alteplase (Activase) Reteplase (rPA, Retevase) |
thrombolytics
|
|
MOA for thrombolytics
|
dissolve clots by activating the conversion of plasminogen to plasmin that hydrolyses fibrin
|
|
Tx for intermittent venous claudication
|
Pentoxifylline (Trental) or Cilostazol (Pletal)
|